Sphera Funds Management’s Assembly Biosciences ASMB Stock Holding History

Sphera Funds Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,354	Closed	-$1.81M	–	80
2019 Q4	$1.81M	Sell	7,354 -2,646	-26%	-$487K	0.15%	78
2019 Q3	$1.18M	Buy	+10,000	New	+$1.51M	0.18%	69
2018 Q4	–	Sell	-8,369	Closed	-$3.73M	–	105
2018 Q3	$3.73M	Buy	+8,369	New	+$3.92M	0.43%	71
2015 Q2	–	Sell	-8,333	Closed	-$1.32M	–	132
2015 Q1	$1.32M	Buy	+8,333	New	+$1.13M	0.14%	126

Other funds holding ASMB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sphera Funds Management's ASMB Position: Q1 2020 in Review

Sphera Funds Management sold out of Assembly Biosciences (ASMB) in Q1 2020, closing a stake of 7,354 shares — an estimated $1.81M sold.

Sphera Funds Management first reported a position in ASMB in Q1 2015 and held it in 4 quarters. The position peaked at $3.73M in Q3 2018. 98 funds tracked by Wall St. Rank hold ASMB as of Q1 2020.

Sphera Funds Management reported no remaining Assembly Biosciences position as of Q1 2020 after selling out during the quarter.
Sphera Funds Management sold 7,354 Assembly Biosciences shares in Q1 2020, an estimated $1.81M.
Sphera Funds Management first reported a position in Assembly Biosciences in Q1 2015 and held it in 4 quarters.
Sphera Funds Management's Assembly Biosciences position peaked at $3.73M in Q3 2018.
98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.